Wealthspire Advisors, LLC Annovis Bio, Inc. Transaction History
Wealthspire Advisors, LLC
- $9.93 Billion
- Q4 2024
A detailed history of Wealthspire Advisors, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 10,050 shares of ANVS stock, worth $27,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,050
Previous 10,000
0.5%
Holding current value
$27,436
Previous $80,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ANVS
# of Institutions
49Shares Held
1.37MCall Options Held
364KPut Options Held
494K-
Vanguard Group Inc Valley Forge, PA466KShares$1.27 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il215KShares$587,5150.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$274,9350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$271,8090.0% of portfolio
-
Merit Financial Group, LLC98.5KShares$268,9480.01% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $22.3M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...